You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
How the FDA became the world's most powerful regulatory agency The U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield its extraordinary power? Reputation and Power traces the history of FDA regulation of pharmaceuticals, revealing how the agency's organizational reputation has been the primary source of its power, yet also one of its ultimate constraints. Daniel Carpenter describes how the FDA cultivated a reputation for competence and vigilance throughout the last century, and how this organizational image has enabled the agency to regulate an industry as powerful as American pharmaceuti...
Advances in Pharmacology and Chemotherapy
Early Phase Drug Evaluation in Man is a comprehensive, practical guide that covers pre-clinical information relevant to early human studies, including pharmaceutical, metabolic, toxicological, and regulatory aspects, as well as the general considerations relevant to all early human studies. Each major therapeutic area is considered by class of activity of drug. The chapters describe what measurements of drug activity are available in healthy human subjects and in patients, how to make the measurements, their value and their limitations. The contributors have been drawn internationally from the pharmaceutical industry and academia. Early Phase Drug Evaluation in Man will provide an important reference guide for industry and academic professionals involved in the development of new drugs.
Until the early 1960s, cancer treatment consisted primarily of surgery and radiation therapy. Most practitioners then viewed the treatment of terminally ill cancer patients with heroic courses of chemotherapy as highly questionable. The randomized clinical trials that today sustain modern oncology were relatively rare and prompted stiff opposition from physicians, who were loath to assign patients randomly to competing treatments. Yet today these trials form the basis of medical oncology. How did such a spectacular change occur? How did medical oncology pivot from a nonentity and, in some regards, a reviled practice to the central position it now occupies in modern medicine? In Cancer on Tri...
Each issue lists papers published during the preceding year.
"Usable Social Science represents a remarkable collaboration between Neil J. Smelser, one of America’s most distinguished sociologists, and John Reed, a highly successful member of corporate America. Together, they accomplish an even more remarkable feat of making accumulated social science knowledge accessible to non-academics while, at the same time, making an academic contribution to the social sciences by reviewing the history, accumulated findings, and conceptual approaches in key areas of specialization in sociology and elsewhere in the social sciences."—Jonathan H. Turner, University Professor & Distinguished Professor of Sociology, University of California, Riverside. “This boo...